IQI
EBS icon

Integrated Quantitative Investments’s Emergent Biosolutions EBS Stock Holding History

Integrated Quantitative Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323K Buy
+38,501
New +$322K 0.05% 321
2025
Q2 		– Sell
-35,023
Closed -$170K – 395
2025
Q1 		$170K Sell
35,023
-6,052
-15% -$50.1K 0.08% 270
2024
Q4 		$393K Buy
+41,075
New +$377K 0.19% 150

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Integrated Quantitative Investments's EBS Position: Q2 2026 in Review

Integrated Quantitative Investments opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 38,501 shares worth $323K. The stake represents 0.05% of the portfolio and ranks #321 among its holdings. This is a return to the name: Integrated Quantitative Investments previously reported a position in EBS as recently as Q1 2025.

Integrated Quantitative Investments first reported a position in EBS in Q4 2024 and has held it in 3 quarters since. The position peaked at $393K in Q4 2024. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Integrated Quantitative Investments held 38,501 shares of Emergent Biosolutions worth $323K as of Q2 2026.
  • Emergent Biosolutions was a new Integrated Quantitative Investments position in Q2 2026.
  • Emergent Biosolutions made up 0.05% of Integrated Quantitative Investments's portfolio in Q2 2026, its #321 holding.
  • Integrated Quantitative Investments first reported a position in Emergent Biosolutions in Q4 2024 and has held it in 3 quarters since.
  • Integrated Quantitative Investments's Emergent Biosolutions position peaked at $393K in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.